Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127237001 | 12723700 | 1 | I | 20160831 | 20160908 | 20160908 | EXP | DE-WEST-WARD PHARMACEUTICALS CORP.-DE-H14001-16-01812 | WESTWARD | ZOELLNER A,WEIGLEIN T,HUTTER G,ZIMMERMANN Y,CIEPLIK H,HESS G,DREYLING M. TEMSIROLIMUS ACTS AS ADDITIVE WITH BENDAMUSTINE IN AGGRESSIVE LYMPHOMA. ANN HEMATOL. 2016;95:403-407. | 65.00 | YR | M | Y | 0.00000 | 20160907 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127237001 | 12723700 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 74290 | |||||||||||
| 127237001 | 12723700 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | 74290 | ||||||||||||
| 127237001 | 12723700 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 127237001 | 12723700 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 127237001 | 12723700 | 5 | SS | CARMUSTINE | CARMUSTINE | 1 | Unknown | 0 | |||||||||||
| 127237001 | 12723700 | 6 | SS | CARMUSTINE | CARMUSTINE | 1 | 0 | ||||||||||||
| 127237001 | 12723700 | 7 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 0 | |||||||||||
| 127237001 | 12723700 | 8 | SS | CYTARABINE. | CYTARABINE | 1 | 0 | ||||||||||||
| 127237001 | 12723700 | 9 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | 0 | |||||||||||
| 127237001 | 12723700 | 10 | SS | MELPHALAN | MELPHALAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127237001 | 12723700 | 1 | Chronic lymphocytic leukaemia |
| 127237001 | 12723700 | 2 | Mantle cell lymphoma |
| 127237001 | 12723700 | 3 | Chronic lymphocytic leukaemia |
| 127237001 | 12723700 | 4 | Mantle cell lymphoma |
| 127237001 | 12723700 | 5 | Chronic lymphocytic leukaemia |
| 127237001 | 12723700 | 6 | Mantle cell lymphoma |
| 127237001 | 12723700 | 7 | Chronic lymphocytic leukaemia |
| 127237001 | 12723700 | 8 | Mantle cell lymphoma |
| 127237001 | 12723700 | 9 | Chronic lymphocytic leukaemia |
| 127237001 | 12723700 | 10 | Mantle cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127237001 | 12723700 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127237001 | 12723700 | Necrotising fasciitis | |
| 127237001 | 12723700 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |